STAAR Surgical Company (STAA)

Oct 30, 2026

STAAR Surgical Company has announced the appointment of Pascal Aeschlimann as vice president of Asia Pacific, effective November 2, 2026. Aeschlimann previously led STAAR's commercial expansion in Asia and the Middle East from 2002 to 2010 and returns after more than a decade building ophthalmic businesses in the region. Based in Singapore, he will lead STAAR's commercial business across the Asia Pacific region, excluding China, focusing on surgeon engagement, clinical education, and patient adoption.

Oct 28, 2026

Staar Surgical (STAA) is projected to experience a year-over-year decline in both earnings and revenues for the quarter ending September 2026, with an expected EPS of $0.19, down 58.7%, and revenues of $81.53 million, a 13.9% decrease. Despite a 20% upward revision in the consensus EPS estimate over the last 30 days, the company's Zacks Earnings ESP of -12.07% combined with a Zacks Rank #1 makes it difficult to definitively predict an earnings beat. Investors should monitor the actual results, expected on November 4, as they could significantly impact the stock's near-term performance.